An article in the Sept. 30, 2015 edition of BioWorld Asia (Genovate emerges with goal to become largest insulin maker in China) incorrectly identified a company as Genovate Biotechnology Co. Ltd. due to an incorrect statement issued by the Public Promotion Department of Changzhou Xinbei District Commission. The company's name is Genova Biotechnology Co. Ltd.